Please Wait
Applying Filters...
menu
    • menu

    List of Drug Master Files (DMF) of Catalase Active Pharmaceutical Ingredient (API) submitted to the U.S. FDA. Original Data : FDA Website

    Client Email Product
    US, Europe turn to advanced manufacturing, stockpiling to strengthen drug supply chains

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Sept 2024: BMS wins landmark FDA approval for schizophrenia med; Sanofi’s Dupixent okayed for COPD

    Stock Recap
    #PipelineProspector

    Menu

    Catalase

    ACTIVE PHARMA INGREDIENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    GLOBAL SALES INFORMATION

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 101Xls download

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Holder DMF No. Subject Submission Date Status Type GDUFA DMF Review GDUFA Review Date GDUFA Payment Date
    26/09/2024 Hubei Gedian Humanwell Pharmaceutical
    China
    		 HUBEI GEDIAN HUMANWELL PHARMACEUTICAL EXCIPIENTS CO LTD 34433 ETHYLPARABEN 2020-01-07 Active IV N/A
    26/09/2024 Roche Diagnostics GmbH
    Germany
    		 BOEHRINGER MANNHEIM GMBH 8106 CATALASE THERAPEUTIC GRADE 1989-06-12 Inactive II N/A